AKT1 and colorectal carcinoma: Inhibition of the Akt signaling pathway, induction of S-phase cell-cycle arrest, inhibition of cellular proliferation and migration, and activation of programmed cell death occurred when the HCT-116 CRC cells were treated with a combination of 5-FU (10μM) and resveratrol (25μM) [209].